BACKGROUND: Lung cancer is one of the leading causes of cancer-related mortality worldwide, with above 80% of cases be non-small cell lung cancer (NSCLC), among which lung squamous cell carcinoma (LUSC) occupies a significant proportion. Although comprehensive cancer therapies have considerably improved the overall survival of patients, patients with advanced LUSC have a poorer prognosis. Therefore, there is a need for a biomarker to predict the progress of advanced LUSC in order to improve prognosis through early diagnosis. Previous studies have shown that miRNAs are differentially expressed in lung cancer tissues and play roles as potential oncogenes or tumor suppressors. The aim of this study is to identify differentially expressed miRNAs between early-stage and advanced-stage LUSC, and to establish a set of miRNAs that can predict the progress of advanced LUSC. METHODS: Clinical data and miRNA-related data of LUSC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Bioinformatic methods were applied to analyze the data. Receiver operating characteristic (ROC) curves were plotted, and various online tools were used to predict target genes, with subsequent analysis of the potential biological mechanisms of these genes. RESULTS: A total of 58 differentially expressed miRNAs were identified between the experiment group and the control group. Seven miRNAs were selected for potential construction of a miRNA biomarker through LASSO regression, and based on the area under the curve (AUC) values of each miRNA, four of these miRNAs (miR-377-3p, miR-4779, miR-6803-5p, miR-3960) were ultimately chosen as biomarkers for predicting advanced LUSC. The AUC under the ROC curve for the combined four miRNAs was 0.865. Enrichment analysis showed that these target genes were involved in several pathways, including cancer-related pathways, mitogen-activated protein kinase (MAPK) signaling pathway, serine/threonine kinase, and tyrosine kinase signaling pathways. CONCLUSIONS The combined use of miR-377-3p, miR-4779, miR-6803-5p and miR-3960 provides a good predictive ability for the progress of advanced LUSC patients, with an AUC of 0.865.
Humans ; MicroRNAs/metabolism* ; Lung Neoplasms/metabolism* ; Biomarkers, Tumor/metabolism* ; Carcinoma, Squamous Cell/pathology* ; Gene Expression Regulation, Neoplastic ; Male ; Female ; Prognosis ; ROC Curve ; Middle Aged

Background and aims:Clinical data regarding patients with chronic hepatitis B(CHB)after Omicron BA.5 infection are currently limited.This study aimed to assess the clinical characteristics of patients with CHB and Omicron BA.5 infection in South China.Methods:This retrospective study was conducted from January to March 2023 in a cohort of 485 healthy individuals and 553 patients with CHB.Clinical features,encompassing COVID-19-related symptoms,levels of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)antibodies,vaccination status,liver functions,and virological markers of hepatitis B virus(HBV)infection were measured.Results:COVID-19-related symptom patterns were similar in both groups,except for fever,which was notably less prevalent(85.4％vs.90.4％,P=0.047)among patients with CHB who experienced a significantly shorter duration of fever(median 2.2(25th-75th percentile,1.0-3.0)days vs.2.3(1.0-3.0)days,P=0.048)and a shorter time for symptom relief(9.2(5.0-14.0)vs.11.1(5.0-14.0)days,P=0.015).The levels of SARS-CoV-2 antibodies were comparable between the two groups but increased after booster vaccinations.In patients with CHB,globulin(GLB)and hepatitis B envelope antibody levels were significantly increased after Omicron BA.5 infection,regardless of nucleos(t)ide analog regimens comparing entecavir(ETV)with tenofovir(TFV).Patients with CHB treated with TFV had significantly higher levels of SARS-CoV-2 antibodies than those treated with ETV(1065.1(346.9-1188.5)COI vs.765.5(24.5-1119.1)COI,P=0.025).Conclusions:No significant exacerbation of COVID-19 symptoms was observed in conjunction with the efficacy of COVID-19 booster vaccinations.There were no notable alterations in liver functions except for GLB.HBV reactivation,as evidenced by increased HBV DNA,was observed among patients with CHB after Omicron BA.5 infection.These changes were not affected by ETV versus TFV administration;however,TFV resulted in a significant increase in SARS-CoV-2 antibody levels.Further studies are required to improve care and therapeutics for patients with CHB who contracted COVID-19.

Objective To construct a human resource allocation model for the Experimental Medicine Department through the measurment of working hour load,in order to achieve accurate and efficient allocation of human resources in the Experimental Medicine Department under the background of medical insurance payment reform.Methods The Department of Experimental Medicine,a 1 100-beds tertiary general hospital in Chengdu,was selected as the research object.The task list method and expert consultation method were used to analyze the work connotation,business process and specific operation of technicians in detail,and the business of laboratory medicine was divided into three dimensions:inspection operation,transactional task and management responsibility.The business operation time of all in-service technicians in the department was measured by stopwatch timing,work sampling,self-recording and back-up interviews,the average value method was used to describe the time consumption of each work step,and the working hours of the work items were counted according to the task list.Combined with the DORATASK model and the standard time concept,a manpower allocation model of the experimental medicine department was established.Results The total time spent of the inspection work was 1 320.82h,the total time of the whole process of the measured transactional work was multiplied by the operation frequency,and the total time spent of the monthly average transactional work was 523.38h,and the average monthly total time spent of the management work was 168 hours by multiplying the number of management positions by the standard working hours.Substituting the data into the model,the average monthly workload of technicians in the hospital was 2 012.2h,and the number of technicians in non-night shift,on-duty or compensatory leave positions was 14 to 15.The measurement results were basically consistent with the number of manpower allocated recommended by experts from multiple departments of the hospital.From 2021 to 2023,the model measurements were continuously tracked,which were consistent with the staffing of the department.Conclusion The human resource allocation model for work hour load adopts quantitative methods,combined with standard time and physiological slack rate,to provide a scientific and flexible path for human resource allocation decision-making.Based on this,the management can gain insight into work intensity and efficiency bottlenecks,implement targeted cost control and manpower optimization,ensure efficient resource utilization and cost control,and promote continuous optimization and upgrading of hospital operation management.

Objective To construct a human resource allocation model for the Experimental Medicine Department through the measurment of working hour load,in order to achieve accurate and efficient allocation of human resources in the Experimental Medicine Department under the background of medical insurance payment reform.Methods The Department of Experimental Medicine,a 1 100-beds tertiary general hospital in Chengdu,was selected as the research object.The task list method and expert consultation method were used to analyze the work connotation,business process and specific operation of technicians in detail,and the business of laboratory medicine was divided into three dimensions:inspection operation,transactional task and management responsibility.The business operation time of all in-service technicians in the department was measured by stopwatch timing,work sampling,self-recording and back-up interviews,the average value method was used to describe the time consumption of each work step,and the working hours of the work items were counted according to the task list.Combined with the DORATASK model and the standard time concept,a manpower allocation model of the experimental medicine department was established.Results The total time spent of the inspection work was 1 320.82h,the total time of the whole process of the measured transactional work was multiplied by the operation frequency,and the total time spent of the monthly average transactional work was 523.38h,and the average monthly total time spent of the management work was 168 hours by multiplying the number of management positions by the standard working hours.Substituting the data into the model,the average monthly workload of technicians in the hospital was 2 012.2h,and the number of technicians in non-night shift,on-duty or compensatory leave positions was 14 to 15.The measurement results were basically consistent with the number of manpower allocated recommended by experts from multiple departments of the hospital.From 2021 to 2023,the model measurements were continuously tracked,which were consistent with the staffing of the department.Conclusion The human resource allocation model for work hour load adopts quantitative methods,combined with standard time and physiological slack rate,to provide a scientific and flexible path for human resource allocation decision-making.Based on this,the management can gain insight into work intensity and efficiency bottlenecks,implement targeted cost control and manpower optimization,ensure efficient resource utilization and cost control,and promote continuous optimization and upgrading of hospital operation management.

BACKGROUND: Lung cancer represents the main cause of cancer-related deaths worldwide, and non-small cell lung cancer (NSCLC) is the most main subtype. More than half of NSCLC patients have already developed distant metastasis (DM) at the time of diagnosis and have a poor prognosis. Therefore, it is necessary to find new biomarkers for predicting NSCLC DM in order to guide subsequent treatment and thus improve the prognosis of NSCLC patients. Numerous studies have shown that microRNAs (miRNAs) are abnormally expressed in lung cancer tissues and play an important role in tumorigenesis and progression. The aim of this study is to identify differentially expressed miRNAs in lung adenocarcinoma tissues with DM group compared to those with non-distant metastasis (NDM) group, and to construct a miRNA signature for predicting DM of lung adenocarcinoma. METHODS: We first obtained miRNA and clinical data for patients with lung adenocarcinoma from The Cancer Genome Atlas (TCGA) database. Subsequently, bioinformatics analysis, which included different R packages, Kaplan-Meier analysis, receiver operating characteristic (ROC) curve, and a range of online analysis tools, was performed to analyze the data. RESULTS A total of 12 differentially expressed miRNAs were identified between the DM and NDM groups, and 8 miRNAs (miR-377-5p, miR-381-5p, miR-490-5p, miR-519d-5p, miR-3136-5p, miR-320e, miR-2355-5p, miR-6784-5p) were screened for constructing a miRNA signature. The efficacy of this miRNA signature in predicting DM was good with an area under the curve (AUC) of 0.831. Logistic regression analysis showed that this miRNA signature was an independent risk factor for DM of lung adenocarcinoma. Next, target genes of the eight miRNAs were predicted, and enrichment analysis showed that these target genes were enriched in a variety of pathways, including pathways in cancer, herpes simplex virus I infection, PI3K-Akt pathway, MAPK pathway, Ras pathway, etc. CONCLUSIONS: This miRNA signature has good efficacy in predicting DM of lung adenocarcinoma and has the potential to be a predictor of DM of lung adenocarcinoma.
Humans ; MicroRNAs/metabolism* ; Lung Neoplasms/diagnosis* ; Male ; Neoplasm Metastasis ; Female ; Gene Expression Regulation, Neoplastic ; Middle Aged ; Prognosis ; Gene Expression Profiling ; Aged ; Biomarkers, Tumor/genetics*

Acquired Hemophilia A is an acquired bleeding disorder characterized by reduced FⅧ activity due to the presence of autoantibodies against anticoagulant factor Ⅷ in the circulation. Laboratory tests are typically characterized by prolonged isolated activated partial thromboplastin time (APTT). Clinically, it often manifests as severe bleeding, and 50% of AHA patients can identify the cause. This article reports on a patient with post-traumatic AHA who rapidly improved after antibody removal and bypass replacement therapy, followed by wound healing following surgical intervention. A review of relevant literature is also conducted to enhance clinicians' awareness of AHA, which presents with normal coagulation initially and gradually develops into prolonged APTT accompanied by bleeding manifestations, aiming for early diagnosis and timely treatment.

Background and purpose:Abnormal DNA methylation is closely associated with the onset and progression of tumors.This study aimed to investigate the expression of intermediate filament family orphan 1(IFFO1),a methylation-driven gene(MDG)in pancreatic adenocarcinoma(PAAD),along with its effects on the invasion and metastasis of PAAD cells,as well as its potential as a diagnostic and prognostic biomarker.Methods:mRNA expression data(TCGA-PAAD-mRNA),DNA methylation data(TCGA-PAAD-meth,GSE53051,PACA-AU)of PAAD and adjacent normal tissues,as well as DNA methylation data of healthy individuals'blood(GSE69270),were obtained from the The Cancer Genome Atlas(TCGA),International Cancer Genome Consortium(ICGC)and Gene Expression Omnibus(GEO)databases.By performing differential expression analysis combined with differential methylation analysis,we screened for MDG in PAAD.In the TCGA database,Pearson correlation tests were employed to verify the relationship between IFFO1 promoter methylation level and its expression level.Additionally,Kaplan-Meier survival analysis was conducted to evaluate the relationship among IFFO1 promoter methylation level,expression level,and the prognosis of PAAD.Pathological sections of cancer tissues and corresponding adjacent tissues from 27 PAAD patients were obtained from Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine.All samples involved in this study were approved by the human ethics committee of Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine(ethics number:hospital ethics review[2017]No.53).Immunohistochemistry staining(IHC)was utilized to detect the expression of IFFO1 in cancer tissues and corresponding adjacent tissues from 27 PAAD patients.Based on the median expression level of IFFO1,patients in the TCGA database were classified into high-expression and low-expression groups.Subsequently,differential analysis,gene ontology(GO)enrichment analysis and gene set enrichment analysis(GSEA)were performed.Western blot and real-time fluorescence quantitative polymerase chain reaction(RTFQ-PCR)were employed to assess the expression variations of IFFO1 between the normal pancreatic ductal epithelial cell line H6C7 and the PAAD cell lines MIA PaCa2,BxPC-3,AsPC-1 and Capan-2.The impact of IFFO1 overexpression on the migration and invasion capacities of PAAD cell lines AsPC-1 and Capan-2 was evaluated using scratch and invasion assays.Additionally,receiver operating characteristic(ROC)curves and Kaplan-Meier survival analysis were utilized to assess the diagnostic and prognostic significance of IFFO1 methylation levels in the TCGA pan-cancer cohort.Results:Through the cross-screening of five datasets,41 MDG in PAAD were identified.Among these,IFFO1 was found to be the gene most closely associated with the prognosis of PAAD[hazard ratio(HR)=0.28,P＜0.001].IFFO1 exhibited high methylation and low expression levels in PAAD.Moreover,a significant negative correlation was observed between the methylation level of its promoter and its expression level(r=-0.55,P＜0.001).IHC results indicated that IFFO1 expression was significantly lower in PAAD tissues than in adjacent non-tumor tissues(P＜0.05).TCGA survival analysis demonstrated that patients with high methylation or low expression of IFFO1 had poorer overall survival(P＜0.05).Both GO and GSEA analyses indicated that the pathway"Negative regulation of cell migration"was enriched in patients with high IFFO1 expression.Western blot and RTFQ-PCR results demonstrated that IFFO1 expression in normal pancreatic ductal epithelial cells H6C7 was significantly higher compared with PAAD cell lines MIA PaCa2,BxPC-3,AsPC-1,and Capan-2.Overexpression of IFFO1 significantly inhibited the migration and invasion of the PAAD cell lines AsPC-1 and Capan-2.Additionally,pan-cancer analysis revealed that IFFO1 exhibited abnormal promoter methylation and low expression across various cancer types,with its methylation levels demonstrating significant diagnostic and prognostic prediction value among different tumors.Conclusion:Promoter hypermethylation results in decreased expression of IFFO1 in PAAD.IFFO1 may suppress the invasion and migration abilities of PAAD cells.Furthermore,IFFO1 methylation holds great promise as a novel biomarker for the diagnosis and prognosis of PAAD.

The senescence accelerate mouse prone strain was identified by Professor T.Takeda's laboratory in Japan from the offspring produced by the brother-sister inbred line of AKR/J mice donated by Jackson Laboratory in the United States SAMP),and SAMP8 mice showed a variety of aging characteristics,such as:Pathological changes such as memory and learning disorders,behavioral abnormalities,skin roughness,aging,hair loss,eye lesions(visual impairment,cataract,periocular lesions),hearing impairment,weight loss,muscle strength loss,reproductive system aging,liver and fat metabolism disorders,etc.,are widely used in experimental studies of related diseases or pathology,and have made considerable contributions to the research of diseases.However,there are also many problems in its application,such as the selection of month age,the use of intervention methods,the suitability of pathological changes and research content,and the understanding of models under different theoretical backgrounds,which are of great research value.Therefore,this paper systematically analyzes the above problems based on existing literature,in order to provide relevant basis for the application of SAMP8 mice in different fields and different mechanisms.

A theoretical study on the differentiation and treatment of Alzheimer's disease by acupuncture and moxibustion based on"kidney-du-brain"system.According to the pathology,symptoms and outcome of Alzheimer's disease,it is identified as"dementia"from the perspective of genesis,and it is believed that the disease location of Alzheimer's disease is in the kidney and brain,and it is closely related to the governor vein,and the core pathogenesis is the kidney deficiency and pulp reduction,the governor vein is not clear,and the brain spirit is not used.It is a sign of deficiency and deficiency.Due to old age and infirmity,congenital loss leads to lack of kidney essence and lack of marrow;Qi and blood deficiency,God has no support and no support;Obstruction of the Dao pulse,Yang stagnation does not cloth,resulting in toxic damage to the brain,god machine lost use.Therefore,based on the"kidney-Du-brain-consciousness"system as the theoretical basis,to benefit the kidney,Tongdu,inspiring God as the treatment principle,to guide the acupuncture treatment of Alzheimer's disease and its complications,the summary is hereby provided for your attention.

"YishentongDu Shengyang"method is based on the physiological and pathological system of"kidney-du-pulp",which is an effective acupuncture treatment method for pulp diseases.Pulp disease,as the name suggests,is located in the pulp and is closely related to the material basis and function of the viscera and the viscera.Its etiology is complex and diverse,its pathogenesis is mixed with deficiency and deficiency,the true and false syndromes are difficult to distinguish,and the paths of transmission are diverse,so the prognosis is often poor.The root of pulp disease is the deficiency of kidney essence,the root of pulp disease is the attenuation of Yuan Yang,and the standard of pulp disease is the blockage of Du pulse.The original"Yishen-Tongdu Shengyang"method to guide acupuncture and moxibustion treatment is intended to tonify kidney essence,smooth Du pulse,and produce Yang qi,which has good effects on pulp disease,supplementing its root,removing its standard and reapplying it.Therefore,we hereby discuss and analyze.